Recruiting × Papillomavirus Infections × Gynecologic × Clear all SHIP-A-S01
Phase NA Recruiting
750 enrolled
POC
Phase NA Recruiting
5,000 enrolled
CASCADE3001A
Phase NA Recruiting
1,600 enrolled
(iSTAR)
Phase NA Recruiting
600 enrolled
RIFT-HPV
Phase 4 Recruiting
69 enrolled
ASHA-Health II
Phase NA Recruiting
420 enrolled
LMI-001-A-S04
Phase NA Recruiting
500 enrolled
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Recruiting
480 enrolled
EQUIP
Phase NA Recruiting
450 enrolled
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Recruiting
50 enrolled
PopSci CHW4CervixHealth
Phase NA Recruiting
120 enrolled
Pocket Colposcopy Using CARE Algorithm
Phase NA Recruiting
1,079 enrolled
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
Phase NA Recruiting
1,000 enrolled
ART-CIN_IIB
Phase 2 Recruiting
78 enrolled
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
Recruiting
250 enrolled
ART-VIN IIB
Phase 2 Recruiting
27 enrolled
HPV
Recruiting
29,750 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
Phase NA Recruiting
40 enrolled
AGO-Gard
Phase 4 Recruiting
250 enrolled
The Organ Transplant Recipient HPV and Skin Cancer Study
Recruiting
1,500 enrolled
KOPRETINA
Phase NA Recruiting
15,000 enrolled
SUIVICIN
Recruiting
200 enrolled
HPV-VIM
Phase 2 Recruiting
85 enrolled
Reducing Urban Cervical Cancer Disparities
Phase NA Recruiting
546 enrolled
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Recruiting
300 enrolled
HERSELF
Phase NA Recruiting
1,000 enrolled
ASTRA
Recruiting
2,000 enrolled
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Phase 3 Recruiting
1,200 enrolled
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 Recruiting
1,348 enrolled
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Recruiting
600 enrolled
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Phase 4 Recruiting
150,000 enrolled